A detailed history of Harbour Capital Advisors, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Harbour Capital Advisors, LLC holds 36,264 shares of MRK stock, worth $4.06 Million. This represents 1.09% of its overall portfolio holdings.

Number of Shares
36,264
Previous 36,204 0.17%
Holding current value
$4.06 Million
Previous $4.78 Million 6.03%
% of portfolio
1.09%
Previous 1.2%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 12, 2024

BUY
$123.8 - $132.96 $7,428 - $7,977
60 Added 0.17%
36,264 $4.49 Million
Q1 2024

Apr 16, 2024

BUY
$113.24 - $131.95 $7,813 - $9,104
69 Added 0.19%
36,204 $4.78 Million
Q4 2023

Jan 05, 2024

BUY
$100.18 - $109.02 $22,340 - $24,311
223 Added 0.62%
36,135 $3.94 Million
Q3 2023

Oct 05, 2023

BUY
$102.95 - $114.33 $86,478 - $96,037
840 Added 2.4%
35,912 $3.7 Million
Q2 2023

Jul 10, 2023

SELL
$108.61 - $118.38 $89,820 - $97,900
-827 Reduced 2.3%
35,072 $4.05 Million
Q1 2023

Apr 19, 2023

BUY
$102.94 - $114.86 $194,968 - $217,544
1,894 Added 5.57%
35,899 $3.82 Million
Q4 2022

Jan 13, 2023

SELL
$87.44 - $112.11 $44,069 - $56,503
-504 Reduced 1.46%
34,005 $0
Q3 2022

Oct 19, 2022

SELL
$84.53 - $94.96 $13,947 - $15,668
-165 Reduced 0.48%
34,509 $3.12 Million
Q2 2022

Jul 20, 2022

BUY
$83.49 - $94.64 $8,766 - $9,937
105 Added 0.3%
34,674 $3.16 Million
Q1 2022

Apr 11, 2022

BUY
$73.51 - $82.4 $22,788 - $25,544
310 Added 0.9%
34,569 $2.84 Million
Q4 2021

Jan 12, 2022

BUY
$72.28 - $90.54 $16,696 - $20,914
231 Added 0.68%
34,259 $2.63 Million
Q3 2021

Oct 13, 2021

BUY
$71.68 - $78.83 $53,760 - $59,122
750 Added 2.25%
34,028 $2.56 Million
Q2 2021

Jul 14, 2021

BUY
$70.31 - $77.77 $40,287 - $44,562
573 Added 1.75%
33,278 $2.59 Million
Q1 2021

Apr 12, 2021

BUY
$68.86 - $81.11 $29,265 - $34,471
425 Added 1.32%
32,705 $2.41 Million
Q4 2020

Jan 12, 2021

BUY
$71.77 - $79.65 $48,516 - $53,843
676 Added 2.14%
32,280 $3,000
Q3 2020

Oct 09, 2020

BUY
$73.18 - $82.95 $35,785 - $40,562
489 Added 1.57%
31,604 $2.62 Million
Q2 2020

Jul 21, 2020

BUY
$70.42 - $80.13 $132,037 - $150,243
1,875 Added 6.41%
31,115 $2.41 Million
Q1 2020

Apr 08, 2020

BUY
$63.36 - $87.82 $84,902 - $117,678
1,340 Added 4.8%
29,240 $2.25 Million
Q4 2019

Jan 22, 2020

BUY
$77.58 - $87.54 $32,583 - $36,766
420 Added 1.53%
27,900 $2.54 Million
Q3 2019

Oct 30, 2019

BUY
$76.08 - $82.93 $187,156 - $204,007
2,460 Added 9.83%
27,480 $2.31 Million
Q2 2019

Jul 10, 2019

BUY
$69.84 - $81.59 $25,491 - $29,780
365 Added 1.48%
25,020 $2.1 Million
Q1 2019

Apr 24, 2019

BUY
$69.58 - $79.36 $20,178 - $23,014
290 Added 1.19%
24,655 $2.05 Million
Q4 2018

Jan 23, 2019

BUY
$65.24 - $75.71 $14,026 - $16,277
215 Added 0.89%
24,365 $1.86 Million
Q3 2018

Nov 07, 2018

BUY
$57.69 - $67.84 $35,652 - $41,925
618 Added 2.63%
24,150 $1.71 Million
Q2 2018

Jul 11, 2018

BUY
$50.83 - $59.72 $175,363 - $206,034
3,450 Added 17.18%
23,532 $1.42 Million
Q1 2018

Apr 18, 2018

BUY
$50.96 - $59.23 $542,520 - $630,562
10,646 Added 112.82%
20,082 $1.09 Million
Q4 2017

Jan 24, 2018

SELL
$51.62 - $61.64 $132,043 - $157,675
-2,558 Reduced 21.33%
9,436 $531,000
Q3 2017

Nov 08, 2017

BUY
$58.67 - $63.13 $703,687 - $757,181
11,994
11,994 $768,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $284B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Harbour Capital Advisors, LLC Portfolio

Follow Harbour Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbour Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Harbour Capital Advisors, LLC with notifications on news.